FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy

Background:FAM46C is a common mutated gene in tumours. A comprehensive understanding of the relationship between FAM46C expression and pan-cancer can guide clinical prognosis and broaden the immunotherapeutic targets.Methods: Data from The Cancer Genome Atlas and Genotype-Tissue Expression (GTEx) da...

Full description

Bibliographic Details
Main Authors: Jiehua Deng, Wei Xiao, Zheng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Genetics
Subjects:
human cancer
immunomodulation
immunotherapy
prognosis
tumour microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.810252/full

Similar Items

Similar Items